London -based GripAble, which provides a platform for neurological therapy and musculoskeletal rehabilitation, has raised $ 11 million in Series A funding.
The round was led by IP Group and Parkwalk Advisors, bringing the total start -up to $ 17.5 million.
GripAble offers a compressible grip to evaluate the strength of the grip. It integrates with a software that allows users to play games to practice hands -on and hands -on exercises. The platform allows patients to set goals and monitor their progress.
The company plans to use the investment to expand its platform into new markets, with a focus on Europe and the US GripAble. It recently announced a joint venture with U.S. medical supplies company Medline.
“Patients with physical and mental health problems should be given medication to improve their quality of life. Simply put, the more rehab they do, the better the more they pay attention to business leadership, the more time they have to achieve better results, with more supporting evidence. This is, “The CEO and founder of GripAble’s Dr. Paul Rinne said in a statement.
“The new funding will extend GripAble’s journey to deliver end -to -end medical care and connect millions to their own medical facility… Our industry leader base in the U.S. market and we can grow. our medical and professional information library. “
Another organization that offers digital therapy for neurological conditions is MindMaze, which works in video games such as medicine and the evaluation of neurodegenerative diseases and brain injuries. The startup announced it was awakening $ 105 million in cash in February, not long after a $ 125 million round from October.
Digital musculoskeletal management and physical therapy are also included a popular place for US digital health publishers. One major player, Hinge Health, raised two major funding rounds last year, with $ 600 million in new investments announced at the end of October.
SWORD Health also increased its circulation in the past year, with a total of $ 163 million in Series D and $ 26 million in double -digit investments. counting $ 2 billion. The company has expanded its line with a new product dealing with female pelvic pain.